Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122303
Filing Date
2024-11-06
Accepted
2024-11-06 16:10:29
Documents
86
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-20240930.htm   iXBRL 10-Q 2894834
2 EX-1.1 rvmd-ex1_1.htm EX-1.1 434383
3 EX-5.1 rvmd-ex5_1.htm EX-5.1 21256
4 EX-10.1 rvmd-ex10_1.htm EX-10.1 280878
5 EX-10.2 rvmd-ex10_2.htm EX-10.2 171804
6 EX-10.3 rvmd-ex10_3.htm EX-10.3 177538
7 EX-31.1 rvmd-ex31_1.htm EX-31.1 16090
8 EX-31.2 rvmd-ex31_2.htm EX-31.2 16049
9 EX-32.1 rvmd-ex32_1.htm EX-32.1 8243
10 EX-32.2 rvmd-ex32_2.htm EX-32.2 8234
11 GRAPHIC img243910505_0.jpg GRAPHIC 198629
12 GRAPHIC img243910505_1.jpg GRAPHIC 326830
13 GRAPHIC img243910505_2.jpg GRAPHIC 328219
14 GRAPHIC img254238869_0.jpg GRAPHIC 19574
15 GRAPHIC img254238869_1.jpg GRAPHIC 6089
  Complete submission text file 0000950170-24-122303.txt   12845576

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20240930.xsd EX-101.SCH 1247471
89 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20240930_htm.xml XML 1942175
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 241431023
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)